Cleared Traditional

K861460 - SOLID STATE CONTINUOUS FLOW CONTROL MODEL W/K101

K861460 is an FDA 510(k) clearance for SOLID STATE CONTINUOUS FLOW CONTROL MOD..., manufactured by Widran Urological Group, Ltd.. The device is a Class 2 Microbiology device with product code LJK cleared through the Traditional 510(k) pathway after a 14-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1986
Decision
14d
Days
Class 2
Risk

K861460 is an FDA 510(k) clearance for the SOLID STATE CONTINUOUS FLOW CONTROL MODEL W/K101. Classified as Antisera, If, Toxoplasma Gondii (product code LJK), Class II - Special Controls.

Submitted by Widran Urological Group, Ltd. (Chicago, US). The FDA issued a Cleared decision on May 2, 1986 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3780 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K861460

510(k) Number K861460 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 18, 1986
Decision Date May 02, 1986
Days to Decision 14 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
88d faster than avg
Panel avg: 102d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJK Device Classification - Class 2, Special Controls

Product Code LJK Antisera, If, Toxoplasma Gondii
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3780
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LJK Antisera, If, Toxoplasma Gondii

Devices cleared under the same product code (LJK) and FDA review panel - the closest regulatory comparables to K861460.
ACCURUN 135 TOXOPLASMA IGG POSITIVE CONTROL
K974261 · Boston Biomedica, Inc. · Dec 1997
ARD(TM) ANTIMICROBIAL REMOVAL DEVICE
K911771 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jul 1991
THE GOLDEN QUAD TEST (TOXO)
K861122 · Microbiological Research Corp. · Feb 1987
TOXO IPA KIT IAN INDIRECT FLUORESCENT
K832069 · Bionetic Laboratory Products · Sep 1983
TOXOPLASMA GONDII ANTIBODY IGG
K822605 · Immulok, Inc. · Oct 1982